휴대용 초음파 기기 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 용도별, 기술별, 지역별, 부문별 예측(2025-2030년)

Handheld Ultrasound Devices Market Growth & Trends:

The global handheld ultrasound devices market size is anticipated to reach USD 442.7 million by 2030, registering a CAGR of 5.74% from 2025 to 2030, according to a new report by Grand View Research, Inc. An increase in patient preference for minimally invasive procedures, rise in the utilization of imaging devices in medical emergencies, also rapid advancements in healthcare technology are key contributors to the market growth. The growing focus on point-of-care ultrasonography and the instantaneous and speedy estimating capabilities of handheld ultrasound devices drive the market growth. The demand for real-time delivery and image-based diagnostic systems has increased, contributing to the market's expansion. Due to their compact size, these devices are ideal for physicians, nurses, and sonographers when traveling to a patient. Doctors can carry them comfortably in their pockets or folders.

In addition, wireless ultrasound devices have made image-seizing for detection and treatment convenient. Hence, using these devices helps avoid complications associated with invasive surgeries. Consequently, surgeons increasingly shift toward noninvasive techniques, such as handheld ultrasound devices. These factors are expected to propel the growth of the market. The increasing product adoption for diagnosis and treatment is boosting the market growth. Handheld ultrasounds are also used in various applications, such as bladder volume, abdominal screening, obstetrics, musculoskeletal, and ultrasound-guided treatment. For instance, as per the World Health Organization (WHO) report of July 2022, about 1.71 billion people suffer from musculoskeletal conditions worldwide. Also, therapeutic handheld ultrasound devices support minimally invasive surgery.

Handheld Ultrasound Devices Market Report Highlights:

• The 3D/4D ultrasound segment dominated the market with the highest revenue share of around 46.69% in 2024, and it is expected to grow at the highest compound annual growth rate (CAGR) of 6.16% from 2025 to 2030.
• Based on application, the musculoskeletal segment dominated the market with a revenue share of 21.53% in 2024.
• The hospital segment held the largest revenue share of 42.09% in 2024. This growth can be attributed to the higher number and type of ultrasound studies performed in hospitals than in any other healthcare setting.
• North America dominated the global market in 2024 with the largest share of around 28.58% by revenue.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technology outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Handheld Ultrasound Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing adoption of handheld ultrasound devices for diagnosis and treatment
    • 3.2.1.2. Rising demand for minimally invasive surgical procedures
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of skilled professionals
    • 3.2.2.2. Limitations of the handheld ultrasound devices
• 3.3. Handheld Ultrasound Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Handheld Ultrasound Devices Market: Technology Estimates & Trend Analysis

• 4.1. Technology Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Handheld Ultrasound Devices Market by Technology Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. 2D Ultrasound
    • 4.4.1.1. 2D ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. 3D/4D Ultrasound
    • 4.4.2.1. 3D/4D ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Doppler Ultrasound
    • 4.4.3.1. Doppler ultrasound market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Handheld Ultrasound Devices Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Handheld Ultrasound Devices Market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Obstetrics/Gynecology
    • 5.4.1.1. Obstetrics/Gynecology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Cardiovascular
    • 5.4.2.1. Cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Urology
    • 5.4.3.1. Urology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Gastroenterology
    • 5.4.4.1. Gastroenterology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Musculoskeletal
    • 5.4.5.1. Musculoskeletal market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Trauma
    • 5.4.6.1. Trauma market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.7. Others
    • 5.4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Handheld Ultrasound Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. Regulatory framework/ reimbursement structure
  • 6.5.2. U.S.
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Competitive scenario
    • 6.5.2.3. Regulatory framework/ Reimbursement structure
    • 6.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Competitive scenario
    • 6.5.3.3. Regulatory framework/ Reimbursement structure
    • 6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Competitive scenario
    • 6.5.4.3. Regulatory framework/ Reimbursement structure
    • 6.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. Regulatory framework/ reimbursement structure
  • 6.6.2. UK
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework/ Reimbursement structure Regulatory framework/ Reimbursement structure
    • 6.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Competitive scenario
    • 6.6.3.3. Regulatory framework/ Reimbursement structure
    • 6.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Competitive scenario
    • 6.6.4.3. Regulatory framework/ Reimbursement structure
    • 6.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Competitive scenario
    • 6.6.5.3. Regulatory framework/ Reimbursement structure
    • 6.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Competitive scenario
    • 6.6.6.3. Regulatory framework/ Reimbursement structure
    • 6.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.7. Norway
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Competitive scenario
    • 6.6.7.3. Regulatory framework/ Reimbursement structure
    • 6.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Competitive scenario
    • 6.6.8.3. Regulatory framework/ Reimbursement structure
    • 6.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Key country dynamics
    • 6.6.9.2. Competitive scenario
    • 6.6.9.3. Regulatory framework/ Reimbursement structure
    • 6.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Regulatory framework/ reimbursement structure
  • 6.7.2. Japan
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework/ Reimbursement structure
    • 6.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework/ Reimbursement structure
    • 6.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework/ Reimbursement structure
    • 6.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.5. Australia
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Competitive scenario
    • 6.7.5.3. Regulatory framework/ Reimbursement structure
    • 6.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.6. South Korea
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Competitive scenario
    • 6.7.6.3. Regulatory framework/ Reimbursement structure
    • 6.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1. Key country dynamics
    • 6.7.7.2. Competitive scenario
    • 6.7.7.3. Regulatory framework/ Reimbursement structure
    • 6.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Regulatory framework/ reimbursement structure
  • 6.8.2. Brazil
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Competitive scenario
    • 6.8.2.3. Regulatory framework/ Reimbursement structure
    • 6.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Competitive scenario
    • 6.8.3.3. Regulatory framework/ Reimbursement structure
    • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. Regulatory framework/ reimbursement structure
  • 6.9.2. South Africa
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Competitive scenario
    • 6.9.2.3. Regulatory framework/ Reimbursement structure
    • 6.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Competitive scenario
    • 6.9.3.3. Regulatory framework/ Reimbursement structure
    • 6.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Competitive scenario
    • 6.9.4.3. Regulatory framework/ Reimbursement structure
    • 6.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key country dynamics
    • 6.9.5.2. Competitive scenario
    • 6.9.5.3. Regulatory framework/ Reimbursement structure
    • 6.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. Key customers
  • 7.3.2. Key company market share analysis, 2024
  • 7.3.3. GE HealthCare
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Koninklijke Philips N.V.
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. BenQ Medical Technology
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. CHISON Medical Technologies Co., Ltd.
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Dawei Medical (Jiangsu) Corp., Ltd.
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Viatom Technology Co., Ltd.
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Telemed Medical Systems S.r.l.
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Butterfly Network, Inc.
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Pulsenmore Ltd.
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Leltek Inc.
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives

Chapter 8. Analyst Perspective